Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$0.16 - $0.47 $400 - $1,175
-2,500 Reduced 11.11%
20,000 $0
Q1 2022

May 10, 2022

SELL
$0.42 - $0.62 $7,518 - $11,098
-17,900 Reduced 44.31%
22,500 $1,000
Q4 2020

Feb 10, 2021

BUY
$0.75 - $2.76 $30,000 - $110,399
40,000 Added 10000.0%
40,400 $16,000
Q3 2020

Oct 27, 2020

SELL
$0.61 - $1.17 $24,156 - $46,332
-39,600 Reduced 99.0%
400 $15,000
Q2 2020

Jul 20, 2020

BUY
$0.47 - $0.72 $18,800 - $28,800
40,000 New
40,000 $13,000
Q4 2019

Feb 10, 2020

SELL
$0.35 - $0.58 $28,175 - $46,690
-80,500 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$0.38 - $0.52 $30,590 - $41,860
80,500 New
80,500 $10,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.